Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Use this HBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Harvard Bioscience Inc even when a live quote feed is slow.
Latest cached year on this hub. Full HBIO income, balance, and cash tables.